- Home
- FTRE vs OMCL Comparison
FTRE vs OMCL Comparison
Compare FTRE & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- OMCL
- Stock Information
- Founded
- FTRE 1996
- OMCL 1992
- Country
- FTRE United States
- OMCL United States
- Employees
- FTRE N/A
- OMCL N/A
- Industry
- FTRE Medical Specialities
- OMCL Computer Manufacturing
- Sector
- FTRE Health Care
- OMCL Technology
- Exchange
- FTRE Nasdaq
- OMCL Nasdaq
- Market Cap
- FTRE 469.0M
- OMCL 1.5B
- IPO Year
- FTRE N/A
- OMCL 2001
- Fundamental
- Price
- FTRE $5.95
- OMCL $25.39
- Analyst Decision
- FTRE Hold
- OMCL Buy
- Analyst Count
- FTRE 11
- OMCL 6
- Target Price
- FTRE $18.00
- OMCL $45.83
- AVG Volume (30 Days)
- FTRE 2.3M
- OMCL 727.0K
- Earning Date
- FTRE 05-12-2025
- OMCL 05-06-2025
- Dividend Yield
- FTRE N/A
- OMCL N/A
- EPS Growth
- FTRE N/A
- OMCL N/A
- EPS
- FTRE N/A
- OMCL 0.45
- Revenue
- FTRE $2,696,400,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- FTRE N/A
- OMCL $3.75
- Revenue Next Year
- FTRE $3.32
- OMCL $4.42
- P/E Ratio
- FTRE N/A
- OMCL $56.43
- Revenue Growth
- FTRE N/A
- OMCL 3.00
- 52 Week Low
- FTRE $4.77
- OMCL $22.66
- 52 Week High
- FTRE $37.24
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- FTRE 43.28
- OMCL 26.13
- Support Level
- FTRE $5.40
- OMCL $22.66
- Resistance Level
- FTRE $6.38
- OMCL $32.18
- Average True Range (ATR)
- FTRE 0.45
- OMCL 1.18
- MACD
- FTRE 0.21
- OMCL -0.46
- Stochastic Oscillator
- FTRE 72.52
- OMCL 28.68
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.